Results 1 to 10 of about 313,837 (264)

Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR)

open access: yesRespiratory Research, 2018
Background Severe and uncontrolled asthma is associated with increased risk of exacerbations and death. A substantial proportion of asthma patients have poor asthma control, and a concurrent COPD diagnosis often increases disease burden. The objective of
Kjell Larsson   +6 more
doaj   +1 more source

Reliability, Satisfaction and Effectiveness of Benralizumab Home Self-Administration in Patients with Severe Eosinophilic Asthma in Real-World Practice: The Auto-Benra Study

open access: yesJournal of Asthma and Allergy, 2022
Ismael García-Moguel,1,2 Ana Rosado,3 Aída Gómez-Cardeñosa,4,5 Mar Gandolfo-Cano,6,7 Teresa Robledo Echarren,8 Maria del Mar Moro Moro,9 Mª del Mar Reaño Martos,10 Rafael Pineda-Pineda,11 Marcela Valverde-Monge,4,5 Cristina Martin-Arriscado Arroba,12 ...
García-Moguel I   +10 more
doaj  

Gender aspects and influence of hormones on bronchial asthma – Secondary publication and update

open access: yesWorld Allergy Organization Journal, 2017
There is good evidence for gender-specific differences in asthma regarding all affected areas, from intra- to extra-cellular mediators to the whole organ structure und functioning of the lung.
Iris Koper, Karin Hufnagl, Rainer Ehmann
doaj   +1 more source

The burden of severe asthma in sub-Saharan Africa: Findings from the African Severe Asthma Project

open access: yesJournal of Allergy and Clinical Immunology: Global
Background: Severe asthma is associated with high morbidity, mortality, and health care utilization, but its burden in Africa is unknown. Objective: We sought to determine the burden (prevalence, mortality, and activity and work impairment) of severe ...
Bruce J. Kirenga, MBChB, MMed, PhD   +19 more
doaj   +1 more source

Efficacy of azithromycin in severe asthma from the AMAZES randomised trial

open access: yesERJ Open Research, 2019
Background Low-dose azithromycin is an effective therapy for persistent asthma; however, its benefit in severe asthma is not defined. Methods Participants with severe asthma were identified from the AMAZES randomised, placebo-controlled trial of long ...
Peter G. Gibson   +11 more
doaj   +1 more source

Asthma Is More Severe in Older Adults.

open access: yesPLoS ONE, 2015
BackgroundSevere asthma occurs more often in older adult patients. We hypothesized that the greater risk for severe asthma in older individuals is due to aging, and is independent of asthma duration.MethodsThis is a cross-sectional study of prospectively
Joe G Zein   +18 more
doaj   +1 more source

Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis

open access: yesERJ Open Research, 2020
Brian D. Kent   +9 more
doaj   +1 more source

Understanding disease burden, challenges in current treatment strategies and call for action for management of severe asthma in Asia: a position statement from Asian respiratory experts

open access: yesFrontiers in Allergy
In the Asia-Pacific region, there is limited data on the full extent of the burden of severe asthma, as well as a lack of clear guidance on improving care standards.
Mariko Siyue Koh   +12 more
doaj   +1 more source

Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis

open access: yesERJ Open Research, 2020
Alexandra M. Nanzer   +11 more
doaj   +1 more source

Mepolizumab and COPD in Real Life

open access: yesOpen Respiratory Archives, 2022
Fernando Revuelta-Salgado   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy